tick-borne encephalitis
Information
- Disease name
- tick-borne encephalitis
- Disease ID
- DOID:0050175
- Description
- "A viral infectious disease that results_in inflammation located_in brain, has_material_basis_in Tick-borne encephalitis virus, which is transmitted_by Ixodes ticks. The infection has_symptom drowsiness, has_symptom confusion, has_symptom sensory disturbances, and has_symptom paralysis." [url:http\://www.cdc.gov/ncidod/dvrd/Spb/mnpages/dispages/TBE.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00118924 | Completed | Phase 1 | Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults | July 2005 | July 2007 |
| NCT00161772 | Completed | Phase 2 | Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. | March 2002 | August 2002 |
| NCT00161785 | Completed | Phase 4 | Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years | June 2004 | July 2005 |
| NCT00161798 | Completed | Phase 2 | Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. | September 2001 | March 2002 |
| NCT00161863 | Completed | Phase 3 | Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years | September 2002 | January 2003 |
| NCT00804219 | Completed | Phase 4 | Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination | December 2008 | November 2010 |
| NCT01361776 | Completed | Phase 2/Phase 3 | Humoral Response to Tick-borne Encephalitis Vaccine in Elderly | September 2011 | June 2014 |
| NCT01710189 | Completed | Phase 4 | Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac | October 2012 | October 2014 |
| NCT02318069 | Completed | Phase 2/Phase 3 | New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly | January 2015 | June 2017 |
| NCT04648241 | Completed | Phase 3 | Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older | January 18, 2021 | February 21, 2022 |
| NCT04573205 | Not yet recruiting | Phase 4 | Primary TBE Vaccination for the Elderly | January 2024 | January 2025 |
| NCT05941546 | Recruiting | Tick-borne Encephalitis Virus Research in Limousin | July 17, 2023 | March 2024 | |
| NCT05607394 | Recruiting | Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases | October 24, 2022 | October 24, 2023 | |
| NCT01031537 | Terminated | Phase 2 | Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) | September 25, 2009 | December 23, 2016 |
| NCT02463942 | Unknown status | N/A | Tick-borne Encephalitis and Positive Borrelial Antibodies | September 2014 | September 2020 |
- Disase is a (Disease Ontology)
- DOID:934
- Cross Reference ID (Disease Ontology)
- GARD:5216
- Cross Reference ID (Disease Ontology)
- ICD10CM:A84.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:063.2
- Cross Reference ID (Disease Ontology)
- MESH:D004675
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:16901001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0014054
- Exact Synonym (Disease Ontology)
- Central European encephalitis
- Exact Synonym (Disease Ontology)
- Far Eastern TBE
- Exact Synonym (Disease Ontology)
- Russian spring-summer encephalitis
- Exact Synonym (Disease Ontology)
- Siberian tick-borne encephalitis
- Exact Synonym (Disease Ontology)
- Taiga encephalitis
- Exact Synonym (Disease Ontology)
- west-Siberian encephalitis
- Exact Synonym (Disease Ontology)
- Western European tick-borne encephalitis
- OrphaNumber from OrphaNet (Orphanet)
- 297
- MedGen concept unique identifier (MedGen Concept name)
- C0014061
- MedGen unique identifier (MedGen Concept name)
- 4034